Proteostasis Therapeutics Inc. (PTI)

2.35 +0.02 (+0.858%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 2.33

Price Open 2.32

Volume: 87,604

Avg Volume: 187,858

Market Cap: 86.24M

P/E Ratio -1.14

52 Wk Range 1.41-8.61



PTI Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
36.27M
2.85M
11.65
7.85%

2018-07-13
35.66M
3.08M
5.18
8.65%

2018-06-29
35.66M
3.57M
3.21
10.02%

2018-06-15
35.66M
2.16M
2.32
6.07%




PTI Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-06-08
Q1 2018
N/A
-0.50 (2)
0.00
0.00

2018-05-11
Q1 2018
N/A
-0.50 (2)
0.00
0.00

2018-05-09
Q1 2018
N/A
-0.51 (2)
-0.32
0.19

2018-03-29
Q4 2017
N/A
-0.67 (2)
0.00
0.00

News

Translate Bio prices upsized initial public offering (2018-06-27 18:47 SeekingAlpha)

Translate Bio ( TBIO ) has priced an upsized initial public offering at $13/share , the midpoint of its range. More news on: Translate Bio, Vertex Pharmaceuticals Incorporated, Galapagos, Healthcare stocks news, IPOs, Read more …

 


Statistics

Shares Outstanding: 36.7M

Top 15 Institution Percent: 64.30

Price To Sales: 17.25

Price To Book: 1.53

Revenue: 2.70M

Gross Profit: N/A

Cash: 100.92M

Debt: N/A

Return On Assets: -76.14

Return On Equity: -100.26

Profit Margin: N/A

Price History

Beta: 3.79

50-day Moving Avg: 2.72

200-day Moving Avg: 3.82

YTD Change: -62.04

5-day Change: -6.00

1-month Change: -15.16

3-month Change: -53.28

6-month Change: -24.92

1-year Change: 15.20

Revenue Per Share: 0.00

Revenue Per Employee: 53960.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Proteostasis Therapeutics Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.proteostasis.com

Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.